{
    "doi": "https://doi.org/10.1182/blood-2020-141773",
    "article_title": "First Results of the Acs\u00e9 Pembrolizumab Phase II in the Primary CNS Lymphoma (PCNSL) Cohort ",
    "article_date": "November 5, 2020",
    "session_type": "626.Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)-Results from Prospective Clinical Trials",
    "abstract_text": "Background: AcS\u00e9 Pembrolizumab is a Phase 2, open-label, single-arm, multi-cohort, multicentric study investigating the efficacy and safety of pembrolizumab monotherapy in patients with advanced rare cancers (NCT03012620). Here, we report the first results of Pembrolizumab in the cohort of Primary Central Nervous System Lymphoma (PCNSL). Methods: Main inclusion criteria were: relapsed or refractory PCNSL after one or several lines of treatment including high dose Methotrexate based chemotherapy, pathologically confirmed diffuse large B cell lymphoma, age>18, HIV negative, concurrent steroid medication at a dose no greater than prednisone 20 mg/day or equivalent. Patients received pembrolizumab 200 mg IV as a 30-minute infusion on Day 1 of every 21-day cycles for a maximum of 2 years. The primary endpoint was the confirmed objective response rate according to IPCG at 84 day after the start of treatment. Secondary endpoints included best response (ORR), duration of response, progression-free survival (PFS), overall survival (OS), and safety. Analysis used all enrolled patients. Results: 50 patients suffering from PCNSL, including 9 primary vitreoretinal lymphoma (PVRL) were included from July, 2017 to October, 2019. Median age was 72 years (range: 43 to 83), Median PS (ECOG) was 1 (range 0-1). The median number of cycles was 4 (range 1-35). At 84 days from start of treatment, 6 patients responded (4 CR+2PR). Overall, 3 patients whose response was not assessed were considered as failures, and the rates of ORR (CR+PR), stable disease (SD), progressive disease (PD) were 26% (13/50, 8 CR + 5 PR), 10% (5/50), 58% (29/50), respectively. ORR was 29% (12/41) and 11% (1/9) in primary cerebral lymphoma and PVRL respectively. After a median follow-up of 6.7 months (range 0.2-27.4), median PFS was 2.6 months, with 6-month PFS of 29.8% and 6-month OS of 60.4%. In responders, median duration of response was estimated at 10 months (95%CI, 2.7 to 12.5). Grade III and IV toxicities related to the drug were observed in 4 patients (8%) and one patient (2%) respectively. No related toxic death was reported. Conclusion: Pembrolizumab shows moderate activity in relapsed/ refractory PCNSL with acceptable toxicity, supporting further studies evaluating its use in combination therapies. Disclosures Hoang-Xuan: BTG: Consultancy, Research Funding. Houot: Bristol-Myers Squibb: Honoraria; MSD: Honoraria; Gilead: Honoraria; Kite: Honoraria; Roche: Honoraria; Novartis: Honoraria; Janssen: Honoraria; Celgene: Honoraria. Schmitt: Celgene: Membership on an entity's Board of Directors or advisory committees; Roche, Janssen: Honoraria. Ahle: Roche: Honoraria; Novartis: Honoraria; Biogene: Honoraria; Abbvie: Honoraria; Sanofi: Honoraria. Bories: Abbvie: Consultancy; Celgen: Consultancy; Gilead: Consultancy; BMS: Honoraria; Novartis: Honoraria. Houillier: BTG: Consultancy.",
    "author_names": [
        "Khe Hoang-Xuan, MDPhD",
        "Roch Houot, MDPhD",
        "Carole Soussain, MD PhD",
        "Marie Blonski, MD",
        "Anna Schmitt, MD",
        "Vincent Delwail, MD",
        "Gandhi Laurent Damaj, MD PhD",
        "Herve Ghesquieres, MD PhD",
        "Fr\u00e9d\u00e9ric Peyrade, MD",
        "Adrian Tempescul, MD",
        "Julie Abraham, MD",
        "Philippe Agape, MD",
        "Guido Ahle, MD",
        "Nathalie Baize, MD",
        "Pierre Bories, MD",
        "Chantal Campello, MD",
        "Emmanuel Gyan, MD PhD",
        "Fabrice Jardin, MD PhD",
        "Philippe Rey, MD",
        "Sylvain Choquet, MD",
        "Caroline Houillier, MD",
        "Nathalie Cassoux, MDPhD",
        "Valerie Touitou, MDPhD",
        "Nadine Martin-Duverneuil, MD",
        "Frederic Legrand",
        "Assia Lamrani-Ghaouti",
        "Ophelie Querel",
        "Natalie Hoog Labouret, MD",
        "Clotilde Simon",
        "Sylvie Chevret, MDPhD",
        "Christophe Massard, MD PhD"
    ],
    "author_dict_list": [
        {
            "author_name": "Khe Hoang-Xuan, MDPhD",
            "author_affiliations": [
                "Department of Neurooncology, La Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Paris, France "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Roch Houot, MDPhD",
            "author_affiliations": [
                "Hematology Department, CHU Rennes, Rennes, France "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carole Soussain, MD PhD",
            "author_affiliations": [
                "Hematology Department, Rene Huguenin Hospital, Institut Curie, Saint-Cloud, France "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marie Blonski, MD",
            "author_affiliations": [
                "CHU Nancy, Nancy, France "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Schmitt, MD",
            "author_affiliations": [
                "Institut Bergoni\u00e9, Bordeaux, France "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Vincent Delwail, MD",
            "author_affiliations": [
                "CIC 802 INSERM, CHU Poitiers, Poitiers, FRA "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gandhi Laurent Damaj, MD PhD",
            "author_affiliations": [
                "CHU de Caen Normandie, Normandie, France "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Herve Ghesquieres, MD PhD",
            "author_affiliations": [
                "Department of Hematology, Centre Hospitalier Lyon-Sud, University Claude Bernard Lyon 1, Pierre Benite, France "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fr\u00e9d\u00e9ric Peyrade, MD",
            "author_affiliations": [
                "Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Adrian Tempescul, MD",
            "author_affiliations": [
                "Department of Hematology, University Hospital of Brest, Brest, France "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Julie Abraham, MD",
            "author_affiliations": [
                "Clinical Hematology Service, CHU Limoges, Limoges, FRA "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Philippe Agape, MD",
            "author_affiliations": [
                "Hematology Department, ICO Rene Gauducheau, Saint-Herblain, France "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guido Ahle, MD",
            "author_affiliations": [
                "Neurology Department, CH Colmar, Colmar, France "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nathalie Baize, MD",
            "author_affiliations": [
                "CHU Angers, Angers, France "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pierre Bories, MD",
            "author_affiliations": [
                "Hematology Laboratory, Onco-occitanie Network, Toulouse University Institute of Cancer-Oncopole, Toulouse, France "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Chantal Campello, MD",
            "author_affiliations": [
                "CHU Marseille, Neurooncology Unit, H\u00f4pital La Timone, Marseille, France "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Emmanuel Gyan, MD PhD",
            "author_affiliations": [
                "Centre Hospitalier Universitaire, Service D'Hemaologie Et Therapie Cellulaire, Tours Cedex, France "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fabrice Jardin, MD PhD",
            "author_affiliations": [
                "Department of Hematology, Centre Henri Becquerel, Rouen, France "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Philippe Rey, MD",
            "author_affiliations": [
                "Hematology, Centre Leon Berard, Lyon, France "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sylvain Choquet, MD",
            "author_affiliations": [
                "Hematology Department, La Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Paris, France "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Caroline Houillier, MD",
            "author_affiliations": [
                "LOC network, La Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Paris, France "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nathalie Cassoux, MDPhD",
            "author_affiliations": [
                "Institut Curie, Paris, FRA "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Valerie Touitou, MDPhD",
            "author_affiliations": [
                "Department of Ophtalmology, AP-HP, H\u00f4Pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris, FRA "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nadine Martin-Duverneuil, MD",
            "author_affiliations": [
                "Department of Neuroradiology, APHP, CHU Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Frederic Legrand",
            "author_affiliations": [
                "Inca, Boulogne Billancourt, France "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Assia Lamrani-Ghaouti",
            "author_affiliations": [
                "Unicancer, Paris, France "
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ophelie Querel",
            "author_affiliations": [
                "Unicancer, Paris, France "
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Natalie Hoog Labouret, MD",
            "author_affiliations": [
                "Inca, Boulogne Billancourt, France "
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Clotilde Simon",
            "author_affiliations": [
                "Unicancer, Paris, France "
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sylvie Chevret, MDPhD",
            "author_affiliations": [
                "APHP, HOPITAL St LOUIS, PARIS, France "
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christophe Massard, MD PhD",
            "author_affiliations": [
                "Gustave Roussy Cancer Campus, Villejuif, France"
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-20T02:29:14",
    "is_scraped": "1"
}